Nutromics Receives FDA Breakthrough Device Designation
Nutromics Receives FDA Breakthrough Device Designation for Wearable Vancomycin Monitoring Patch Nutromics, a medical technology company developing a wearable lab-on-a-patch™ platform for continuous molecular monitoring, announced that the U.S. Food…
One Biosciences Secures €3.3M France 2030 Funding for Breast Cancer Diagnostic
One Biosciences and Institut Curie Secure €3.3 Million France 2030 Funding to Advance Single-Cell Diagnostics for Triple-Negative Breast Cancer One Biosciences, a techbio company spun out of Institut Curie and…
Exegenesis Bio and Modalis Collaborate to Advance MDL-201 for Duchenne Muscular Dystrophy
Exegenesis Bio and Modalis Partner to Advance MDL-201 Gene Therapy for Duchenne Muscular Dystrophy Exegenesis Bio and Modalis Therapeutics Corporation (TOKYO: 4883) have entered into a research collaboration and license…
Johnson & Johnson Receives CE Mark for ACUVUE OASYS MAX Reusable Contact Lenses
Johnson & Johnson Receives CE Mark for ACUVUE OASYS MAX 2-Week Reusable Contact Lens Johnson & Johnson (NYSE: JNJ) announced that it has received CE Marking for ACUVUE OASYS MAX…
Yarrow Bioscience Announces Proposed Public Offering
Yarrow Bioscience Launches Underwritten Public Offering to Support Autoimmune Thyroid Disease Pipeline Yarrow Bioscience, Inc., a clinical-stage biotechnology company focused on developing transformative therapies for autoimmune thyroid diseases, has announced…
Kallisio Expands Patient Access to FDA-Cleared Stentra™ Mouthpiece for Head and Neck Cancer Radiation Therapy
Kallisio Expands Patient Access Program for Stentra in Head and Neck Cancer Radiation Therapy Kallisio has announced an expanded patient access program designed to help people preparing for radiation therapy…
Mobile Heartbeat Expands Clinical Communication Network with Private 5G Support
Mobile Heartbeat Expands Banyan Platform with Private 5G Support for Healthcare Communications Mobile Heartbeat, a provider of clinical communication and collaboration solutions, has announced that its Banyan platform now supports…
IMDS Launches NHanceIT™ Microcatheter in U.S. for Complex PCI
IMDS Launches NHanceIT Microcatheter in the U.S. for Complex Coronary Interventions Interventional Medical Device Solutions (IMDS), a specialty catheter company developing purpose-built technologies for complex percutaneous coronary intervention (PCI), chronic…
BioLab Holdings Expands Placental Membrane Portfolio with New Hydrated Amnion Membrane
BioLab Holdings Expands Placental Membrane Portfolio With New Membrane Wrap Amniotic Hydro BioLab Holdings, Inc., a Phoenix-based medical technology company focused on tissue restoration, has expanded its portfolio of placental…
Seaport Therapeutics Reports Positive Phase 1 Results for GlyphAllo in Driving Simulation Trial
PureTech Health Notes Positive Phase 1 Driving Trial Results for GlyphAllo in Major Depressive Disorder PureTech Health plc (LSE: PRTC), a biotherapeutics company operating through a hub-and-spoke model to translate…
InduPro Publishes Nature Study Establishing Spatial Protein Proximity Framework for Therapeutic Discovery
InduPro Publishes Nature Study Defining New Proximity-Based Targets for Cancer Therapeutics InduPro, Inc., a biotechnology company developing novel therapeutics for cancer and autoimmune diseases through protein proximity biology, has announced…
TRIANA Biomedicines Publishes Preclinical Data Supporting Clinical Development of TRI-611
TRIANA Biomedicines Publishes Nature Study Supporting TRI-611 Molecular Glue Therapy for ALK-Positive NSCLC TRIANA Biomedicines, Inc. (TRIANA), a clinical-stage biopharmaceutical company focused on developing molecular glue therapies against difficult-to-drug disease…